摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-methoxybenzyl)-1H-pyrrole | 79499-35-7

中文名称
——
中文别名
——
英文名称
2-(2-methoxybenzyl)-1H-pyrrole
英文别名
2-(o-Methoxybenzyl)pyrrole;2-(2-Methoxy-benzyl)-1h-pyrrole;2-[(2-methoxyphenyl)methyl]-1H-pyrrole
2-(2-methoxybenzyl)-1H-pyrrole化学式
CAS
79499-35-7
化学式
C12H13NO
mdl
——
分子量
187.241
InChiKey
FVIOROBJXUURKY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    313.1±22.0 °C(Predicted)
  • 密度:
    1.093±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    25
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    2-(2-methoxybenzyl)-1H-pyrrole1,1'-双(二苯基膦)二茂铁potassium tert-butylate双氧水 、 palladium diacetate 、 sodium hydride 、 sodium hydroxide 作用下, 以 乙醇二甲基亚砜N,N-二甲基甲酰胺 为溶剂, 反应 0.25h, 生成 2-(((1r,4r)-4-hydroxycyclohexyl)amino)-4-(2-(2-methoxybenzyl)-1H-pyrrol-1-yl)benzamide
    参考文献:
    名称:
    Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold
    摘要:
    Glucose regulated protein 94 kDa, Grp94, is the endoplasmic reticulum (ER) localized isoform of heat shock protein 90 (Hsp90) that is responsible for the trafficking and maturation of toll-like receptors, immunoglobulins, and integrins. As a result, Grp94 has emerged as a therapeutic target to disrupt cellular communication, adhesion, and tumor proliferation, potentially with fewer side effects compared to pan- inhibitors of all Hsp90 isoforms. Although, the N-terminal ATP binding site is highly conserved among all four Hsp90 isoforms, recent cocrystal structures of Grp94 have revealed subtle differences between Grp94 and other Hsp90 isoforms that has been exploited for the development of Grp94-selective inhibitors. In the current study, a structure-based approach has been applied to a Grp94 nonselective compound, SNX 2112, which led to the development of 8j (ACO1), a Grp94-selective inhibitor that manifests,similar to 440 nM affinity and >200-fold selectivity against cytosolic Hsp90 isoforms.
    DOI:
    10.1021/acschembio.6b00747
  • 作为产物:
    描述:
    参考文献:
    名称:
    Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold
    摘要:
    Glucose regulated protein 94 kDa, Grp94, is the endoplasmic reticulum (ER) localized isoform of heat shock protein 90 (Hsp90) that is responsible for the trafficking and maturation of toll-like receptors, immunoglobulins, and integrins. As a result, Grp94 has emerged as a therapeutic target to disrupt cellular communication, adhesion, and tumor proliferation, potentially with fewer side effects compared to pan- inhibitors of all Hsp90 isoforms. Although, the N-terminal ATP binding site is highly conserved among all four Hsp90 isoforms, recent cocrystal structures of Grp94 have revealed subtle differences between Grp94 and other Hsp90 isoforms that has been exploited for the development of Grp94-selective inhibitors. In the current study, a structure-based approach has been applied to a Grp94 nonselective compound, SNX 2112, which led to the development of 8j (ACO1), a Grp94-selective inhibitor that manifests,similar to 440 nM affinity and >200-fold selectivity against cytosolic Hsp90 isoforms.
    DOI:
    10.1021/acschembio.6b00747
点击查看最新优质反应信息

文献信息

  • [EN] GRP94 SELECTIVE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS SÉLECTIFS DE GRP94 ET LEURS UTILISATIONS
    申请人:UNIV KANSAS
    公开号:WO2018081814A1
    公开(公告)日:2018-05-03
    The present technology provides compounds according to Formula I or Formula III as well as compositions including such compounds useful for the treatment of metastatic cancer and/or glaucoma.
    目前的技术提供了根据公式I或公式III提供的化合物,以及包括这些化合物的组合物,用于治疗转移性癌症和/或青光眼。
  • Grp94 selective inhibitors and uses thereof
    申请人:University of Kansas
    公开号:US10975030B2
    公开(公告)日:2021-04-13
    The present technology provides compounds according to Formula I or Formula III as well as compositions including such compounds useful for the treatment of metastatic cancer and/or glaucoma.
    本技术提供了根据式 I 或式 III 的化合物以及包括此类化合物的组合物,可用于治疗转移性癌症和/或青光眼。
  • [EN] Z-TYPE SOLANONE, PREPARATION METHOD THEREFOR, AND USE<br/>[FR] SOLANONE DE TYPE Z, PROCÉDÉ DE PREPARATION ASSOCIÉ, ET UTILISATION<br/>[ZH] 一种(Z)型茄酮、其制备方法及用途
    申请人:CHINA TOBACCO YUNNAN IND CO LTD
    公开号:WO2021068530A1
    公开(公告)日:2021-04-15
    本发明公开了一种(Z)型茄酮,其立体结构式为 (I) 或 (II) ,其名称为:(S,Z)-5-异丙基-8-甲基-6,8-二烯-2-酮、或(R,Z)-5-异丙基-8-甲基-6,8-二烯-2-酮。本发明还公开了所述(Z)型茄酮的制备方法及用卷烟烟丝加香的用途。
  • Tandem alkylation-reduction of 2-acylpyrroles. Convenient one-pot syntheses of 2-benzylpyrroles
    作者:Doris P. Schumacher、Stan S. Hall
    DOI:10.1021/jo00338a002
    日期:1981.12
  • SCHUMACHER, D. P.;HALL, S. S., J. ORG. CHEM., 1981, 46, N 25, 5060-5064
    作者:SCHUMACHER, D. P.、HALL, S. S.
    DOI:——
    日期:——
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯